Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Access

Set Alert for Market Access

Medicare Bonus Payments: CMS Plans To End Three, But Considers Seven New-Tech Add-On Payments For FY 2019

While the US Medicare agency is proposing to end hospital inpatient new-technology add-on payments for Edwards Lifesciences’ and LivaNova’s minimally surgical valves, and for WL Gore's endoprosthesis aneurysm device, it is evaluating possible bonus payments for 7 more devices beginning Oct. 1.

Reimbursement Market Access Medicare
Advertisement

Latest From Market Access

QUOTED. May 7, 2018. Jim Cross.

Electrophysiologists are running into challenges in getting subcutanous ICDs covered by private insurers. See why consultant and former Aetna executive Jim Cross thinks that could change this year based on recently updated guidelines.

Market Access Reimbursement

Experimental Or Established? Clinicians, Insurers Debate S-ICDs

Despite many electrophysiologists' enthusiasm for less-invasive cardiac rhythm management devices, insurers are frequently denying coverage of Boston Scientific's Emblem subcutaneous implantable cardioverter defibrillator (S-ICD) for patients, citing what they argue is a lack of adequate clinical data that shows them to be better than "experimental." Boston Scientific recently sponsored a virtual roundtable of physicians to discuss how new professional society guidelines are influencing prescribing and reimbursement of these devices.

Market Access Reimbursement

Medtech Buyers Care Most About Positive Patient Outcomes, Durability When Assessing Products, Survey Finds

Attributes that best differentiate medical devices in a competitive market are: low risk, those that work well for the task demanded, consistent outcomes, good patient outcomes, and proven and trusted brands, according to a survey by marketing analytics firm Vennli. Device manufacturers must be willing to make changes in marketing messages to stand out from the competition, the firm says.

Market Access Advertising, Marketing & Sales

Orthopedists Asked CMS To Stop Mandatory Bundled-Pay Models

Orthopedic surgeons never favored mandatory bundled-payment programs such as the Comprehensive Care for Joint Replacement model. In fact, in comments to CMS, surgeons requested that the US Center for Medicare and Medicaid Innovation make the programs voluntary and scale them back.

Orthopedics Reimbursement

More Changes Ahead For Medtech In South Africa As Final Reg Structure Nears

South Africa's medtech industry has much to look forward to, given the emergence of the new South African Health Products Regulatory Authority (SAHPRA) and the sheer volume of activity in recent years dedicated to establishing the mechanisms to secure fully regulated, safe and high-quality medical devices. But it's not the end of the road; there remain some tricky stretches ahead, including new "pricing" regulations, as discussed at the 2018 MedTech Forum.

South Africa Regulation

Medtechs Must Address South Africa Market With Serious Intent And Sensitivity

South Africa is like no other country, having emerged through difficult decades of social inequality to now be embracing, among other things, modern health-care delivery via new regulatory structures, a national development plan and a National Health Insurance program (NHI). It is a potentially lucrative opportunity, but medtech players need to be wise to particular localization needs when embracing the South African market.

South Africa Market Access
See All
UsernamePublicRestriction

Register